BAJAJ BROKING

Notification close image
No new Notification messages
card image
Amanta Healthcare Ltd IPO
Apply for the Amanta Healthcare Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

540694

ANG

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ANG Lifesciences India Limited Share Price Update

As of the latest trading session, ANG Lifesciences India Limited share price is currently at ₹ 24.61, which is down by ₹ -1.09 from its previous closing. Today, the stock has fluctuated between ₹ 24.52 and ₹ 26.73. Over the past year, ANG Lifesciences India Limited has achieved a return of -47.75 %. In the last month alone, the return has been -14.50 %. Read More...

Investment Returns

Over 1 Month -14.50% Over 3 Months -11.37% Over 6 Months -22.61% Over 1 Year -47.75%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ANG Lifesciences India Limited fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    32.10

  • P/E Ratio (TTM)

    -4.01

  • Beta

    0.01

  • Book Value / share

    51.16

  • Return on equity

    -8.72%

  • EPS (TTM)

    0.00

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    -0.79

info icon alternate text

ANG Lifesciences India Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 24.53
Operating Expense 25.74
Net Profit -0.79
Net Profit Margin (%) -3.22
Earnings Per Share (EPS) -0.59
EBITDA 2.03
Effective Tax Rate (%) 23.30
Particulars MAR 2025 (Values in Cr)
Revenue 17.67
Operating Expense 21.37
Net Profit -1.94
Net Profit Margin (%) -10.97
Earnings Per Share (EPS) -1.50
EBITDA 0.38
Effective Tax Rate (%) 34.45
Particulars DEC 2024 (Values in Cr)
Revenue 23.91
Operating Expense 29.44
Net Profit -4.57
Net Profit Margin (%) -19.11
Earnings Per Share (EPS) -3.50
EBITDA -2.01
Effective Tax Rate (%) 17.98
Particulars SEP 2024 (Values in Cr)
Revenue 32.16
Operating Expense 33.19
Net Profit -1.07
Net Profit Margin (%) -3.32
Earnings Per Share (EPS) -0.75
EBITDA 2.82
Effective Tax Rate (%) -61.19
Particulars JUN 2024 (Values in Cr)
Revenue 16.18
Operating Expense 21.28
Net Profit -2.77
Net Profit Margin (%) -17.11
Earnings Per Share (EPS) -2.12
EBITDA -0.57
Effective Tax Rate (%) 26.13
Particulars MAR 2025 (Values in Cr)
Revenue 89.91
Operating Expense 105.28
Net Profit -10.34
Net Profit Margin (%) -11.50
Earnings Per Share (EPS) -7.86
EBITDA 0.62
Effective Tax Rate (%) 20.01
Particulars MAR 2024 (Values in Cr)
Revenue 131.37
Operating Expense 139.34
Net Profit -8.65
Net Profit Margin (%) -6.58
Earnings Per Share (EPS) -6.48
EBITDA 8.21
Effective Tax Rate (%) 2.48
Particulars MAR 2023 (Values in Cr)
Revenue 207.01
Operating Expense 214.76
Net Profit -0.66
Net Profit Margin (%) -0.31
Earnings Per Share (EPS) 0.04
EBITDA 20.91
Effective Tax Rate (%) 131.88
Particulars MAR 2022 (Values in Cr)
Revenue 348.67
Operating Expense 296.56
Net Profit 39.71
Net Profit Margin (%) 11.38
Earnings Per Share (EPS) 38.51
EBITDA 66.03
Effective Tax Rate (%) 25.16
Particulars MAR 2021 (Values in Cr)
Revenue 154.28
Operating Expense 145.16
Net Profit 7.25
Net Profit Margin (%) 4.69
Earnings Per Share (EPS) 12.63
EBITDA 15.68
Effective Tax Rate (%) 26.47
Particulars MAR 2024 (Values in Cr)
Book Value / Share 54.82
ROE % -10.56
ROCE % 1.43
Total Debt to Total Equity 0.88
EBITDA Margin 7.28
Particulars MAR 2023 (Values in Cr)
Book Value / Share 62.43
ROE % -0.21
ROCE % 8.31
Total Debt to Total Equity 0.87
EBITDA Margin 10.74
Particulars MAR 2022 (Values in Cr)
Book Value / Share 76.28
ROE % 48.13
ROCE % 35.05
Total Debt to Total Equity 0.92
EBITDA Margin 19.42
Particulars MAR 2024 (Values in Cr)
Book Value / Share 58.74
ROE % -8.72
ROCE % 1.71
Total Debt to Total Equity 0.71
EBITDA Margin 7.78
Particulars MAR 2023 (Values in Cr)
Book Value / Share 61.91
ROE % -0.46
ROCE % 7.81
Total Debt to Total Equity 0.69
EBITDA Margin 9.99
Particulars MAR 2022 (Values in Cr)
Book Value / Share 76.00
ROE % 63.62
ROCE % 49.10
Total Debt to Total Equity 0.83
EBITDA Margin 19.07
Particulars MAR 2021 (Values in Cr)
Book Value / Share 76.99
ROE % 19.10
ROCE % 19.05
Total Debt to Total Equity 0.83
EBITDA Margin 10.42
Particulars MAR 2020 (Values in Cr)
Book Value / Share 66.67
ROE % 19.27
ROCE % 20.74
Total Debt to Total Equity 0.67
EBITDA Margin 10.13
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 5.73
Total Assets 242.43
Total Liabilities 242.43
Total Equity 76.27
Share Outstanding 13058287
Price to Book Ratio 0.77
Return on Assets (%) -4.18
Return on Capital (%) -6.97
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.17
Total Assets 277.66
Total Liabilities 277.66
Total Equity 86.21
Share Outstanding 13058287
Price to Book Ratio 1.23
Return on Assets (%) -0.09
Return on Capital (%) -0.17
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 6.65
Total Assets 291.03
Total Liabilities 291.03
Total Equity 83.76
Share Outstanding 10366630
Price to Book Ratio 3.09
Return on Assets (%) 13.85
Return on Capital (%) 25.08
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 5.49
Total Assets 217.42
Total Liabilities 217.42
Total Equity 77.07
Share Outstanding 13058287
Price to Book Ratio 0.77
Return on Assets (%) -3.97
Return on Capital (%) -6.51
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.05
Total Assets 252.50
Total Liabilities 252.50
Total Equity 85.53
Share Outstanding 13058287
Price to Book Ratio 1.23
Return on Assets (%) -0.26
Return on Capital (%) -0.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 6.58
Total Assets 268.68
Total Liabilities 268.68
Total Equity 83.48
Share Outstanding 10366630
Price to Book Ratio 3.09
Return on Assets (%) 14.78
Return on Capital (%) 27.49
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 142.24
Total Liabilities 142.24
Total Equity 41.35
Share Outstanding 5183315
Price to Book Ratio 1.11
Return on Assets (%) 5.09
Return on Capital (%) 8.66
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.60
Total Assets 94.07
Total Liabilities 94.07
Total Equity 34.55
Share Outstanding 5183315
Price to Book Ratio 0.45
Return on Assets (%) 6.47
Return on Capital (%) 11.56
Particulars MAR 2024 (Values in Cr)
Net Income -10.71
Cash from Operations 3.91
Cash from Investing 19.89
Cash from Financing -10.40
Net change in Cash 0.00
Free Cash Flow 9.48
Particulars MAR 2023 (Values in Cr)
Net Income 2.62
Cash from Operations 29.83
Cash from Investing -9.32
Cash from Financing -17.07
Net change in Cash -0.02
Free Cash Flow 40.28
Particulars MAR 2022 (Values in Cr)
Net Income 53.50
Cash from Operations 25.24
Cash from Investing -44.40
Cash from Financing 19.92
Net change in Cash 0.23
Free Cash Flow 66.58
Particulars MAR 2024 (Values in Cr)
Net Income -8.86
Cash from Operations 0.26
Cash from Investing 20.01
Cash from Financing -7.00
Net change in Cash -0.11
Free Cash Flow 5.70
Particulars MAR 2023 (Values in Cr)
Net Income 2.06
Cash from Operations 29.36
Cash from Investing -9.34
Cash from Financing -16.74
Net change in Cash -0.08
Free Cash Flow 39.80
Particulars MAR 2022 (Values in Cr)
Net Income 53.06
Cash from Operations 27.97
Cash from Investing -42.50
Cash from Financing 15.28
Net change in Cash 0.17
Free Cash Flow 67.31
Particulars MAR 2021 (Values in Cr)
Net Income 9.86
Cash from Operations -10.55
Cash from Investing -7.78
Cash from Financing 18.80
Net change in Cash -0.16
Free Cash Flow -6.48
Particulars MAR 2020 (Values in Cr)
Net Income 6.09
Cash from Operations 7.48
Cash from Investing -1.65
Cash from Financing -3.94
Net change in Cash -0.77
Free Cash Flow 9.12
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.16 12.72 1.70 238.79 30.00 / 69.50
BLISS GVS PHARMA LTD 158.10 15.64 1.58 1667.92 105.05 / 190.65
CIPLA LTD 1587.60 23.78 4.11 128239.04 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 322.55 9.08 2.61 949.30 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.16 16.93 4.92 238.79 30.00 / 69.50
AMRUTAJAN HEALTH LTD 720.55 38.21 6.37 2083.16 548.05 / 838.00
ASTRAZENECA PHARMA IND LT 8751.75 103.46 28.40 21879.38 6222.35 / 10653.05
BLISS GVS PHARMA LTD 158.10 23.63 1.57 1667.92 105.05 / 190.65

ANG Lifesciences India Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
24.61 -4.24 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 27.30
  • 26 Days 29.30
  • 10 Days 28.10
  • 50 Days 29.60
  • 12 Days 28.40
  • 100 Days 30.80
  • 20 Days 29.10
  • 200 Days 35.40
26.36 PIVOT

First Support

24.72

First Resistance

27.33

Second Support

23.75

Second Resistance

28.97

Third Support

22.11

Third Resistance

29.94

RSI

29.66

ADX

8.83

MACD

-0.91

Williams % R

-94.55

Commodity Channel Index (CCI)

-169.05

Date

2025-09-01

Week

4425.00

Same Day

8087.00

Month

6353.00

1 Year

0.01

3 Year

0.28

Over 1 Month

-14.50%

down

Over 1 Year

-47.75%

down

Over 3 Months

-11.37%

down

Over 3 Years

-44.61%

down

Over 6 Months

-22.61%

down

Over 5 Years

6.91%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

ANG Lifesciences India Limited shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

ANG Lifesciences India Limited corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
02 Nov 2021 1.0 Interim 04 Nov 2021 Equity shares
Ex-Date Ex-Bonus Ratio
14 Jul 2022 13 Jul 2022 1:4
23 Sep 2021 22 Sep 2021 1:1
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

ANG Lifesciences India Limited Share Price

ANG Lifesciences India Limited was originally incorporated as a Private Limited Company with the name 'ANG Lifesciences India Private Limited' on June 14, 2006. On conversion into Public Limited Company, the name was changed to ANG Lifesciences India Limited on March 02, 2010. The Company further converted into Private Limited Company and the name of the Company was changed to 'ANG Lifesciences India Private Limited' on September 22, 2010. Subsequently, on conversion into Public Limited Company, the name again changed to 'ANG Lifesciences India Limited' on May 18, 2016.

The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulation in the form of Sterile Dry Powder Injection Vials. In 2008-09, the Company started its commercial production. In 2014-15, it commenced direct sale of medicines covering hospitals , Doctors through stockists.

The Company is ISO-9001:2008 certified, which manufacture its products in compliance with GMP requirements. Company has dedicated area, machinery, facilities and advanced equipment for manufacturing of Beta Lactum & Non Beta Lactum products as per GMP norms. The Company currently operates a strong manufacturing set-up consisting of 4 formulation plants situated at Baddi, Himachal Pradesh. These state-of-art facilities have integrated process development teams with in-house engineering capabilities and well equipped with quality control laboratories with most modern and validate analytical equipment. It also has geographical presence across India, Africa, Gulf countries & other ROW countries.

In August, 2017, the Company came up with a Public Issue of 15,00,800 Equity Shares by raising money from public aggregating to Rs 12 Crore.

The Company acquired Mansa Printers & Publishers Limited in April, 2021 for backward integration in pharma packaging to optimize costs and ensure timely availability of packaging products.

Parent organization Indian Private
NSE symbol [-]
Founded 2006
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of ANG Lifesciences India Ltd?

Answer Field

ANG Lifesciences India Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 24.61 as on Sep 02 2025 03:26 PM.

What is the Market Cap of ANG Lifesciences India Ltd Share?

Answer Field

The market cap of ANG Lifesciences India Ltd for NSE ₹ 0.00 & for BSE ₹ 32.10 as on Sep 02 2025 03:26 PM.

What is the 52 Week High and Low of ANG Lifesciences India Ltd?

Answer Field

The 52 Week High and Low of ANG Lifesciences India Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 62.75 and ₹ 21.03.

What is 1 year return for ANG Lifesciences India Ltd?

Answer Field

The 1 year returns on the stock has been -47.75%.

What is the P/E Ratio of ANG Lifesciences India Ltd Share?

Answer Field

As on Sep 02 2025 03:26 PM the price-to-earnings (PE) ratio for ANG Lifesciences India Ltd share is -4.01.

What is the PB ratio of ANG Lifesciences India Ltd Share?

Answer Field

As on Sep 02 2025 03:26 PM, the price-to-book (PB) ratio for ANG Lifesciences India Ltd share is 51.16.

How to Buy ANG Lifesciences India Ltd Share?

Answer Field

You can trade in ANG Lifesciences India Ltd shares with Bajaj Broking by opening a demat account.

How to Buy ANG Lifesciences India Ltd Share on Bajaj Broking App?

Answer Field

To buy ANG Lifesciences India Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “ANG Lifesciences India Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91